David Tak Yan Yu

8.1k total citations
121 papers, 4.9k citations indexed

About

David Tak Yan Yu is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, David Tak Yan Yu has authored 121 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 55 papers in Rheumatology and 20 papers in Hematology. Recurrent topics in David Tak Yan Yu's work include Spondyloarthritis Studies and Treatments (45 papers), Rheumatoid Arthritis Research and Therapies (40 papers) and T-cell and B-cell Immunology (26 papers). David Tak Yan Yu is often cited by papers focused on Spondyloarthritis Studies and Treatments (45 papers), Rheumatoid Arthritis Research and Therapies (40 papers) and T-cell and B-cell Immunology (26 papers). David Tak Yan Yu collaborates with scholars based in United States, Germany and China. David Tak Yan Yu's co-authors include Henry G. Kunkel, Robert Winchester, Shu Man Fu, H S Ko, Philip J. Clements, Harold E. Paulus, James B. Peter, Jieruo Gu, Peter Schwimmbeck and Michael B. A. Oldstone and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

David Tak Yan Yu

118 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tak Yan Yu United States 36 2.5k 2.0k 747 737 722 121 4.9k
A D Steinberg United States 34 2.7k 1.1× 1.8k 0.9× 1.1k 1.4× 565 0.8× 268 0.4× 84 5.0k
Nabih I. Abdou United States 34 1.7k 0.7× 969 0.5× 749 1.0× 398 0.5× 353 0.5× 107 3.6k
J. R. Batchelor United Kingdom 37 2.6k 1.0× 1.0k 0.5× 542 0.7× 465 0.6× 513 0.7× 97 4.9k
Zev Sthoeger Israel 33 1.8k 0.7× 1.1k 0.5× 565 0.8× 877 1.2× 415 0.6× 119 4.0k
Ronald P. Messner United States 37 2.4k 0.9× 1.2k 0.6× 848 1.1× 1.0k 1.4× 280 0.4× 102 5.2k
Patrick J Venables United Kingdom 47 1.7k 0.7× 3.5k 1.7× 1.5k 2.0× 1.4k 1.9× 349 0.5× 131 7.1k
Laurence A. Rubin Canada 32 2.3k 0.9× 1.0k 0.5× 354 0.5× 827 1.1× 418 0.6× 71 5.7k
Peter M. Lydyard United Kingdom 38 3.5k 1.4× 545 0.3× 1.4k 1.8× 1.3k 1.7× 414 0.6× 149 5.4k
M A Vadas Australia 30 2.9k 1.2× 545 0.3× 305 0.4× 1.2k 1.7× 562 0.8× 48 5.5k
Hisao Tomioka Japan 34 1.8k 0.7× 777 0.4× 530 0.7× 634 0.9× 143 0.2× 140 3.9k

Countries citing papers authored by David Tak Yan Yu

Since Specialization
Citations

This map shows the geographic impact of David Tak Yan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tak Yan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tak Yan Yu more than expected).

Fields of papers citing papers by David Tak Yan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tak Yan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tak Yan Yu. The network helps show where David Tak Yan Yu may publish in the future.

Co-authorship network of co-authors of David Tak Yan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of David Tak Yan Yu. A scholar is included among the top collaborators of David Tak Yan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tak Yan Yu. David Tak Yan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Minghui, Kang Dong, Haoran Li, et al.. (2025). Graphitic carbon cage structure encapsulating cobalt nanoparticles in nitrogen-doped biomass-derived carbon materials enables high-performance sodium–sulfur batteries. Journal of Materials Chemistry A. 13(45). 39150–39162.
2.
Tam, Lai‐Shan, Jieruo Gu, & David Tak Yan Yu. (2010). Pathogenesis of ankylosing spondylitis. Nature Reviews Rheumatology. 6(7). 399–405. 161 indexed citations
3.
Gu, Jieruo, James Cheng‐Chung Wei, Feng Huang, et al.. (2009). Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome‐wide expression profiling and real‐time polymerase chain reaction. Arthritis & Rheumatism. 60(11). 3269–3279. 27 indexed citations
4.
Robinson, William H., Beren H. Tomooka, Rafael Valle‐Oñate, et al.. (2008). Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. 25 indexed citations
5.
Yu, David Tak Yan, et al.. (2006). Panamerican Congress of Spondyloarthropathies, Cartagena, Columbia, October 20-22, 2005: Latin American rheumatology comes of age!. PubMed. 33(5). 983–4. 1 indexed citations
6.
Li, Jin, Ge Zhang, Joshua M. Akey, et al.. (2004). Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis & Rheumatism. 50(9). 3047–3048. 14 indexed citations
7.
Kuipers, Jens G., M. C. Jendro, Vera Rebmann, et al.. (2002). The genetically-engineered secretory B27/Q10 chimeric molecule inhibits HLA-B27 restricted alloreactive T-lymphocytes.. PubMed. 20(4). 455–62. 7 indexed citations
8.
Huang, Feng, Akihiro Yamaguchi, Naoyuki Tsuchiya, et al.. (1997). Induction of alternative splicing of HLA‐B27 by bacterial invasion. Arthritis & Rheumatism. 40(4). 694–703. 27 indexed citations
9.
Kuipers, Jens G., Richard B. Raybourne, Kristina M. Williams, H. Zeidler, & David Tak Yan Yu. (1996). Specificities of human tap alleles for HLA—B27 binding peptides. Arthritis & Rheumatism. 39(11). 1892–1895. 4 indexed citations
10.
11.
Fukazawa, Toru, Feng Huang, Dolly B. Tyan, et al.. (1994). Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies.. The Journal of Immunology. 152(3). 1190–1196. 15 indexed citations
12.
Yu, David Tak Yan, Toru Fukazawa, H. Kellner, et al.. (1994). A monoclonal antibody that recognizes HLA-B27 in the context of peptides.. The Journal of Immunology. 152(3). 1197–1205. 39 indexed citations
13.
Hermann, E, K-H Meyer zum Büschenfelde, Bernhard Fleischer, & David Tak Yan Yu. (1993). HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. The Lancet. 342(8872). 646–650. 286 indexed citations
14.
Yu, David Tak Yan & Robert D. Inman. (1991). Infectious agents and other nongenetic immunologic factors in spondyloarthropathies. Current Opinion in Rheumatology. 3(4). 581–585. 1 indexed citations
15.
Williams, Kristina M., et al.. (1989). Synthetic oligonucleotide probes complementary to the HLA-B variable region hybridize with Klebsiella pneumoniae. Microbial Pathogenesis. 6(4). 277–286. 6 indexed citations
16.
Yu, David Tak Yan, et al.. (1989). Molecular Mimicry in HLA-B27-Related Arthritis. Annals of Internal Medicine. 111(7). 581–591. 36 indexed citations
17.
Yong, Zhou, et al.. (1988). An experimental mouse model of Yersinia-induced reactive arthritis. Microbial Pathogenesis. 4(4). 305–310. 15 indexed citations
18.
Ko, H S, Shu Man Fu, Robert Winchester, David Tak Yan Yu, & Henry G. Kunkel. (1979). Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.. The Journal of Experimental Medicine. 150(2). 246–255. 389 indexed citations
19.
Yu, David Tak Yan, et al.. (1978). Effect of corticosteroids on committed lymphocytes.. PubMed Central. 32(3). 545–53. 10 indexed citations
20.
Fan, Peng, David Tak Yan Yu, Philip J. Clements, & Rodney Bluestone. (1978). Human monocyte-lymphocyte interaction: Rosette formation between monocytes and lymphoblastoid cell lines. Clinical Immunology and Immunopathology. 9(3). 363–370. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A D Steinberg Breakdown of academic impact, for papers by Nabih I. Abdou Breakdown of academic impact, for papers by J. R. Batchelor Breakdown of academic impact, for papers by Zev Sthoeger Breakdown of academic impact, for papers by Ronald P. Messner Breakdown of academic impact, for papers by Patrick J Venables Breakdown of academic impact, for papers by Laurence A. Rubin Breakdown of academic impact, for papers by Peter M. Lydyard Breakdown of academic impact, for papers by M A Vadas Breakdown of academic impact, for papers by Hisao Tomioka
Rankless by CCL
2026